Aurora Cannabis Inc. (ACB) News
Filter ACB News Items
ACB News Results
|Loading, please wait...|
ACB News Highlights
- ACB's 30 day story count now stands at 43.
- Over the past 20 days, the trend for ACB's stories per day has been choppy and unclear. It has oscillated between 1 and 19.
- KIRK, BEAT and GOLD are the most mentioned tickers in articles about ACB.
Latest ACB News From Around the Web
Below are the latest news stories about Aurora Cannabis Inc that investors may wish to consider to help them evaluate ACB as an investment opportunity.
Investing $5,000 in companies that compete in a growing industry like cannabis can be great for your portfolio. With trailing revenue of $589.31 million, it also has a claim to being one of the world's leaders in the cannabis space.
Are any Canadian marijuana stocks buys now, after Canopy Growth and Aurora Cannabis reported earnings?
The stock market has dropped in the past four months, but many equities have been southbound for much longer than that. Let's look at two stocks that have dropped by more than 60% in the trailing-12-month period: Aurora Cannabis (NASDAQ: ACB) and Ocugen (NASDAQ: OCGN). The market reacted positively to Aurora Cannabis' latest earnings report, which was for the second quarter of its fiscal year 2022, ending on Dec. 31.
Investment Thesis Aurora Cannabis (ACB) cannot commit to a set direction. As the costs of its failures mount, it is difficult to see how management will reclaim the company’s former glory in an oversaturated cannabis industry. Industry Overview For years, SA writers, investors, and Reddit-lurkers alike have bolstered the marijuana...
The downward trend on TLRY stock might soon come to an end, amid an encouraging financial picture and increasing rumors that the cannabis legislation is close to a loosening in its core markets.
Both pot companies'' recent quarterly results were bleak, but one has a better chance to rebound.
Key Takeaways; Cannabis Sector Schwazze completed $75 million acquisition. Israeli medical cannabis company InterCure reported its preliminary Q4 financial results. Cannabis REIT Chicago Atlantic lent $34 million to FarmaceuticalRX. Red White & Bloom closed the acquisition of Michigan marijuana operator PharmaCo. Weak cannabis sales drove Canopy Growth Q3 revenue 8% lower to C$115 million. Aurora […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared first on Market Exc
U.S. marijuana legalization has come a long way, but it still has a long way to go.
Megacaps drew attention last week amid continued volatility in the markets. SA readers jumped into Meta (FB), Amazon (AMZN) and Alphabet (GOOGL)(GOOG). They dropped Aurora Cannabis (ACB).
In a report released today, Vivien Azer from Cowen & Co. maintained a Hold rating on Aurora Cannabis (ACB – Research Report), with a price target of C$7.00. The company's shares closed last Friday at $4.72, close to its 52-week low of $3.71. According to TipRanks.com, Azer is a 5-star analyst with an average return of 16.1% and a 59.4% success rate. Azer covers the Consumer Goods sector, focusing on stocks such as Constellation Brands, Altria Group, and Boston Beer. Aurora Cannabis has an analyst consensus of Hold, with a price target consensus of $5.42, implying a 21.0% upside from current levels.